Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

Called the photovoltaic retina implant microarray (PRIMA), the small system uses a subretinal ... The researchers said they ...

Michael O'Connell, Chief Analytics Officer at Spotfire, on his journey to technology leadership in energy management ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

The treatment involves inserting a tiny implant thinner than human hair under the retina. Patients then have to wear glasses that project near-infrared light to the implant.

AI translates electrical signals to the brain to help restore reading vision to treat a common form of blindness that was ...